Abiopharma

New Form SCHEDULE 13D/A - Mersana Therapeutics, Inc. Filed: 2026-01-08 AccNo: 0001193125-26-007752 Size: 11 KB

Cavalier Jason 🔴 sold 769 shares of Lyra Therapeutics, Inc. (LYRA) at $3.36 Transaction Date: Jan 06, 2026 | Filing ID: 007760

Palasis Maria 🔴 sold 1.7K shares of Lyra Therapeutics, Inc. (LYRA) at $3.36 Transaction Date: Jan 06, 2026 | Filing ID: 007751

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Cellectis Announces 2026 Strategy and Catalysts

📋 Almstead Zheng Yang (Member of immediate family of any of the foregoing) plans to sell 59 shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $5K) Filed: Jan 08, 2026 | ID: 000225

New Form SCHEDULE 13D - IRIDEX CORP Filed: 2026-01-08 AccNo: 0002097627-26-000007 Size: 20 KB

📋 VanDuyn Amy Beth (Officer) plans to sell 3K shares of Phreesia, Inc. (at $17.01 each, total $44K) Filed: Jan 08, 2026 | ID: 000224

📋 Hoffman Allison C (Officer) plans to sell 7K shares of Phreesia, Inc. (at $17.01 each, total $112K) Filed: Jan 08, 2026 | ID: 000223

📋 Almstead Neil Gregory (Officer) plans to sell 881 shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $67K) Filed: Jan 08, 2026 | ID: 000222

📋 Lyssikatos Joseph P (Officer) plans to sell 82K shares of Enliven Therapeutics, Inc. (at $15.47 each, total $1.3M) Filed: Jan 08, 2026 | ID: 000005

📋 Heyman Richard A. (Director) plans to sell 2K shares of Enliven Therapeutics, Inc. (at $15.47 each, total $25K) Filed: Jan 08, 2026 | ID: 000004

📋 LAURA A WILLIAMS (Officer) plans to sell 50K shares of ARDELYX INC (at $5.83 each, total $292K) Filed: Jan 08, 2026 | ID: 000286